Craft

Bluejay Diagnostics

Stock Price

$0.1

2024-10-29

Market Capitalization

$1.8 M

2024-10-29

Revenue

$249 K

FY, 2022

Bluejay Diagnostics Summary

Company Summary

Overview
Bluejay Diagnostics is a company that develops, manufactures, and markets point-of-care medical diagnostic tests. It offers Allereye, a device that helps healthcare providers to diagnose ocular allergies and allergic conjunctivitis. In addition, the company delivers urine-based HIV-1 screening and confirmatory tests.
Type
Public
Status
Active
Founded
2015
HQ
Acton, MA, US | view all locations
Website
https://bluejaydx.com/
Cybersecurity rating
Sectors

Key People

  • Neil Dey

    Neil Dey, President, Chief Executive Officer & Director

  • Jason Cook

    Jason Cook, Chief Technology Officer

  • Kevin Vance

    Kevin Vance, Chief Commercial Officer

    • Douglas C. Wurth

      Douglas C. Wurth, Chairman of the Board

    LocationsView all

    1 location detected

    • Acton, MA HQ

      United States

      360 Massachusetts Ave #203

    Bluejay Diagnostics Financials

    Summary Financials

    Net income (Q1, 2026)
    ($1.9M)
    Cash (Q1, 2026)
    $3.7M
    EBIT (Q1, 2026)
    ($1.9M)
    Enterprise value
    ($1.7M)

    Footer menu